Paper36948133
Protective effect of sodium butyrate on intestinal barrier damage and uric acid reduction in hyperuricemia mice.
Li Y and 5 others. Biomed Pharmacother, 2023. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Protective effect of sodium butyrate on intestinal barrier damage and uric acid reduction in hyperuricemia mice. Papers, record 36948133. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36948133
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protective effect of sodium butyrate on intestinal barrier damage and uric acid reduction in hyperuricemia mice.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyperuricemia | Major topic |
| Humans | |
| Mice | |
| Animals | |
| Butyric Acid | |
| Uric Acid | |
| Occludin | |
| Caco-2 Cells | |
| Mice, Inbred C57BL | |
| Fatty Acids, Volatile | |
| Disease Models, Animal |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940323 | Resveratrol Ameliorates Hyperuricemia in Association with Remodeling of the Gut Microbiota-Metabolism Axis: An Integrated 16S rDNA Sequencing and Fecal Metabolomics Study. | Foods | 2026 | https://conductscience.org/library/papers/42940323 | PubMed |
| 42796621 | Saponins Derived from Chinese Medicinal Materials in Hyperuricemia and Gout: Therapeutic Mechanisms and Emerging Perspectives. | Molecules | 2026 | https://conductscience.org/library/papers/42796621 | PubMed |
| 42719332 | Structural characterization of a novel low-molecular-weight β-fructan from Panax quinquefolius and its effect on ameliorating hyperuricemia. | J Ginseng Res | 2026 | https://conductscience.org/library/papers/42719332 | PubMed |
| 42627078 | 6'‑O‑Caffeoylarbutin attenuates experimental hyperuricemia by regulating renal and intestinal urate transport, intestinal barrier integrity, and gut microbiota. | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42627078 | PubMed |
| 42513105 | Mechanisms of Gut Microbiota-Derived Metabolites in Treating Hyperuricemia: Natural Products as Interventions. | Molecules | 2026 | https://conductscience.org/library/papers/42513105 | PubMed |
| 42396658 | ABCG2 transporter: Structural and functional associations with gout (Review). | Int J Mol Med | 2026 | https://conductscience.org/library/papers/42396658 | PubMed |
| 42243132 | Gut microbiota-associated N-Acetyl-L-leucine mediates fructose-induced hyperuricemia via the P300-URAT1 pathway. | NPJ Sci Food | 2026 | https://conductscience.org/library/papers/42243132 | PubMed |
| 42221486 | The roles of gut microbiota and their metabolites in uric acid-related metabolic diseases: mechanisms and therapeutic targets. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42221486 | PubMed |
| 42210528 | Multi-target effects of Limosilactobacillus reuteri RE225 on hyperuricemia through xanthine oxidase inhibition, nucleoside degradation, gut microbiota modulation, and renal TLR4-NF-κB suppression. | J Sci Food Agric | 2026 | https://conductscience.org/library/papers/42210528 | PubMed |
| 42158395 | Research progress on the correlation between gut microbiota and the occurrence of hyperuricemia. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42158395 | PubMed |
| 42006120 | Gut microbiota: a potential therapeutic target for hyperuricemia and gout. | Biosci Microbiota Food Health | 2026 | https://conductscience.org/library/papers/42006120 | PubMed |
| 41933530 | Effects of protease-hydrolyzed cottonseed protein on growth performance, intestinal morphology, and bacterial diversity in broilers. | Poult Sci | 2026 | https://conductscience.org/library/papers/41933530 | PubMed |
| 41868377 | Complex interactions of gut-derived short-chain fatty acids in hyperuricemia and gout pathophysiology. | Front Microbiol | 2026 | https://conductscience.org/library/papers/41868377 | PubMed |
| 41847428 | Identification and Validation of Key Purine Metabolism-Related Genes in Ulcerative Colitis Using Bioinformatics and Machine Learning. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/41847428 | PubMed |
| 41838319 | The Nonlinear Relationship Between Serum Uric Acid and Cardiovascular Disease Risk: Mechanistic Insights and Clinical Implications. | Cardiovasc Drugs Ther | 2026 | https://conductscience.org/library/papers/41838319 | PubMed |
| 41703989 | Lactobacillus paragasseri LG-1 Alleviates Urticaria-Like Symptoms in Mice via Modulation of Gut Microbiota, Hypoxanthine and Uric Acid. | Microb Biotechnol | 2026 | https://conductscience.org/library/papers/41703989 | PubMed |
| 41625162 | Differential impact of sodium butyrate forms on intestinal morphology, gene expression, and growth performance in broiler chickens under cold stress at high altitude. | Vet Anim Sci | 2026 | https://conductscience.org/library/papers/41625162 | PubMed |
| 41272772 | Gut microbiome restoring biogenic ferritin mineral as an effective oral iron supplement for iron deficiency anemia. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41272772 | PubMed |
| 41127097 | Lactobacillus paracasei N1115 alleviates hyperuricemia in mice: regulation of uric acid metabolism as well as its impact on gut microbiota and short-chain fatty acids. | Front Nutr | 2025 | https://conductscience.org/library/papers/41127097 | PubMed |
| 41012372 | Evaluation of the Effects of High Uric Acid on Glucolipid Metabolism, Renal Injury and the Gut Microbiota in Diabetic Male Hamsters with Dyslipidemia. | Toxics | 2025 | https://conductscience.org/library/papers/41012372 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| OCLN | 100506658 | PubTator's text mining | https://conductscience.org/library/genes/100506658 | NCBI Gene |
| TJP1 | 7082 | PubTator's text mining | https://conductscience.org/library/genes/7082 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36948133
GET https://conductscience.org/api/papers/v1/36948133/cited_by?page=2